Connect Biopharma (CNTB) News Today $0.98 -0.02 (-2.00%) As of 06/30/2025 03:56 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNTB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Q2 Earnings Forecast for CNTB Issued By HC WainwrightJune 16, 2025 | marketbeat.comConnect Biopharma Reports Positive Clinical Results for Rademikibart in Eosinophilic-Driven Type 2 Asthma PatientsJune 15, 2025 | nasdaq.comConnect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual CongressJune 13, 2025 | globenewswire.comConnect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual CongressJune 3, 2025 | globenewswire.comConnect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International ConferenceMay 20, 2025 | globenewswire.comConnect Biopharma Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | globenewswire.comConnect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPDMay 14, 2025 | globenewswire.comConnect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in AsthmaMay 13, 2025 | globenewswire.comConnect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International ConferenceApril 24, 2025 | globenewswire.comBullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVApril 11, 2025 | markets.businessinsider.comConnect Biopharma announces feedback from FDA Type C meeting for RademikibartApril 2, 2025 | markets.businessinsider.comConnect Biopharma publishes results from rademikibart trialApril 1, 2025 | markets.businessinsider.comConnect Biopharma Announces Positive Type C Meeting with the FDA for RademikibartApril 1, 2025 | globenewswire.comConnect Biopharma reports FY24 (28c) vs ($1.13) last yearMarch 31, 2025 | markets.businessinsider.comConnect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled AsthmaMarch 31, 2025 | globenewswire.comConnect Biopharma Reports 2024 Full-Year Financial Results and Provides Business UpdateMarch 31, 2025 | globenewswire.comConnect Biopharma faces Nasdaq delisting over share priceMarch 30, 2025 | uk.investing.comConnect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementMarch 28, 2025 | globenewswire.comConnect Biopharma to Present at Two Upcoming Investor ConferencesMarch 3, 2025 | globenewswire.comConnect Biopharma Holdings And Two Other Promising Penny Stocks To WatchFebruary 28, 2025 | finance.yahoo.comBrokers Offer Predictions for CNTB FY2024 EarningsFebruary 10, 2025 | marketbeat.comFY2029 Earnings Estimate for CNTB Issued By Leerink PartnrsFebruary 7, 2025 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Shares Down 0.8% - Should You Sell?January 21, 2025 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 53.5% in DecemberDecember 28, 2024 | marketbeat.comConnect Biopharma Appoints New Accounting FirmDecember 23, 2024 | tipranks.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 7.4% in NovemberDecember 16, 2024 | marketbeat.comConnect Biopharma Hldgs (NASDAQ:CNTB) Stock, Option ChainNovember 14, 2024 | benzinga.comShort Interest in Connect Biopharma Holdings Limited (NASDAQ:CNTB) Increases By 26.7%October 30, 2024 | marketbeat.comAttovia Therapeutics Appoints Chief Financial OfficerOctober 15, 2024 | globenewswire.comCNTB Stock Surges Over 5% Amid Strong Financial PerformanceOctober 2, 2024 | gurufocus.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Sees Large Growth in Short InterestOctober 1, 2024 | marketbeat.comCentessa Pharmaceuticals: Progressing SerpinPC Through Registrational Trials In Hemophilia BSeptember 25, 2024 | seekingalpha.comSimcere Pharmaceutical Group Ltd (S2P.DU)September 25, 2024 | sg.finance.yahoo.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 76.0% in AugustSeptember 13, 2024 | marketbeat.comConnect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024September 10, 2024 | finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Connect Biopharma (NASDAQ:CNTB)September 6, 2024 | marketbeat.comConnect Biopharma Reports First Half 2024 Financial Results and Provides Business UpdateSeptember 5, 2024 | globenewswire.comShort Interest in Connect Biopharma Holdings Limited (NASDAQ:CNTB) Decreases By 9.7%September 1, 2024 | marketbeat.comConnect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth PlansAugust 29, 2024 | finance.yahoo.comConnect Biopharma Holdings Limited Share ChatAugust 25, 2024 | lse.co.ukConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 44.2% in JuneJuly 12, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest UpdateJuly 1, 2024 | marketbeat.comConnect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics ForumJuly 1, 2024 | globenewswire.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 34.6% in MayJune 16, 2024 | marketbeat.comConnect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 12, 2024 | globenewswire.comConnect Biopharma Announces New Leadership and Chair of the Board of DirectorsJune 12, 2024 | globenewswire.comConnect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe AsthmaMay 22, 2024 | globenewswire.comConnect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe AsthmaMay 7, 2024 | globenewswire.comConnect Biopharma Holdings Limited (CNTB)April 26, 2024 | finance.yahoo.comBML Capital Management LLC Makes New $2.43 Million Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)April 24, 2024 | marketbeat.com Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address CNTB Media Mentions By Week CNTB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTB News Sentiment▼1.890.90▲Average Medical News Sentiment CNTB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTB Articles This Week▼10▲CNTB Articles Average Week Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CGC News Today TVGN News Today BTMD News Today INBX News Today DSGN News Today ESPR News Today NBTX News Today MDWD News Today CRDF News Today IMAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTB) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredTrump Makes Major Crypto AnnouncementTrumps “Secret Weapon” for Crypto Dominance There's a growing push for America to lead the next wave of dig...Crypto 101 Media | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
